Micro-RNAs in gastrointestinal and liver disease - PubMed (original) (raw)

Review

. 2008 Dec;135(6):1866-9.

doi: 10.1053/j.gastro.2008.10.074. Epub 2008 Nov 14.

Affiliations

• PMID: 19013167
• DOI: 10.1053/j.gastro.2008.10.074

Review

Micro-RNAs in gastrointestinal and liver disease

Rosa Visone et al. Gastroenterology. 2008 Dec.

No abstract available

PubMed Disclaimer

Similar articles

• Gastrointestinal and liver diseases: genetic and epigenetic markers.
  Blum HE. Blum HE. Gut. 2011 Dec;60(12):1630-4. doi: 10.1136/gut.2010.213462. Epub 2011 Sep 2. Gut. 2011. PMID: 21890815 Review. No abstract available.
• Genetic association studies: from "searching under the lamppost" to "fishing in the pond".
  El-Serag HB, White DL, Mitra N. El-Serag HB, et al. Gastroenterology. 2008 Mar;134(3):662-4. doi: 10.1053/j.gastro.2008.01.025. Gastroenterology. 2008. PMID: 18325382 No abstract available.
• Impact of modern molecular methods on studies of gastrointestinal and liver diseases.
  [No authors listed] [No authors listed] Hepatology. 1987 Jan-Feb;7(1 Suppl):1S-78S. Hepatology. 1987. PMID: 3804211 No abstract available.
• [Molecular biology 1996: gastroenterology and hepatology].
  Blum HE. Blum HE. Praxis (Bern 1994). 1997 Jul 16;86(29-30):1172-7. Praxis (Bern 1994). 1997. PMID: 9333917 Review. German.
• The molecular basis of inherited disorders of the gastrointestinal and hepatobiliary tracts. An update on recent progress.
  Martín MG, Turk E. Martín MG, et al. Gastroenterol Clin North Am. 1995 Mar;24(1):45-70. Gastroenterol Clin North Am. 1995. PMID: 7729861 Review.

Cited by

• MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.
  Bai S, Nasser MW, Wang B, Hsu SH, Datta J, Kutay H, Yadav A, Nuovo G, Kumar P, Ghoshal K. Bai S, et al. J Biol Chem. 2009 Nov 13;284(46):32015-27. doi: 10.1074/jbc.M109.016774. Epub 2009 Sep 2. J Biol Chem. 2009. PMID: 19726678 Free PMC article.
• Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action.
  Yang X, Pang YY, He RQ, Lin P, Cen JM, Yang H, Ma J, Chen G. Yang X, et al. FEBS Open Bio. 2017 Dec 20;8(1):64-84. doi: 10.1002/2211-5463.12349. eCollection 2018 Jan. FEBS Open Bio. 2017. PMID: 29321958 Free PMC article.
• Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma.
  Zhang M, Zhou X, Wang B, Yung BC, Lee LJ, Ghoshal K, Lee RJ. Zhang M, et al. J Control Release. 2013 Jun 28;168(3):251-61. doi: 10.1016/j.jconrel.2013.03.020. Epub 2013 Apr 6. J Control Release. 2013. PMID: 23567045 Free PMC article.
• MiRNAs and cancer.
  Visone R, Croce CM. Visone R, et al. Am J Pathol. 2009 Apr;174(4):1131-8. doi: 10.2353/ajpath.2009.080794. Epub 2009 Mar 5. Am J Pathol. 2009. PMID: 19264914 Free PMC article. Review.
• miRNAs in precancerous lesions of the gastrointestinal tract.
  Fassan M, Croce CM, Rugge M. Fassan M, et al. World J Gastroenterol. 2011 Dec 28;17(48):5231-9. doi: 10.3748/wjg.v17.i48.5231. World J Gastroenterol. 2011. PMID: 22219591 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Medical

  • MedlinePlus Health Information